chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented to clinic 2 days after vaccines with redness and tenderness at injection site. Area of redness is 6 x 6.5 cm increased warmth and tenderness. No swelling. Treated with AUGMENTIN 800mg BID x10 days.
states "a little while after the second shot, I began to have more issues where my coccyx injury is and I feel like it's killing me; I don't know if it's from  the shot targeting that spot or something else but it's been ongoing since March 2021; I've had H pylori on/off since then and three diagnosed Urinary Tract Infections since then"
This initial spontaneous report was received on 18-MAY-2017 from a pharmacist and a 61 year old female patient. Medical history and concomitant medications were not provided. On approximately 30-MAR-2017 (reported as seven weeks ago), the pt received ZOSTAVAX) for prevention of shingles (lot # M037015; expiration 22-NOV-2017).  The pharmacist reported that the patient experienced itching on an unspecified place on her body for the last seven weeks. She was treated by an unspecified number or doctors with unspecified oral steroids, antihistamines and steroid creams with no relief. The patient reported that she has experienced itching since the ZOSTAVAX vaccine. She itches from her head to her feet. She reported that the itch has "destroyed her life" and she cannot have a normal day anymore because of the constant itching. On an unspecified date, she developed a huge rash on both shins from her ankles to her knees. The patient's physician sent her to a dermatologist. The dermatologist referred her to a psychiatrist. The psychiatrist prescribed an unspecified medication for schizophrenia and bipolar disorder. The patient was also referred to a hematologist. She stated she was prescribed may unspecified medications. The patient feels the company should pay for all of her doctor bills and medications that she has been taking. She also wanted something for her "pain and suffering". The patient stated that the product is "bad" and that she was not at all happy and that she is in agony. She will be telling people not to get the shot. The outcome of the events were not recovered. The pharmacist did not rate causality. Upon internal review, schizophrenia and bipolar disorder were considered medically significant. Additional information has been requested.
sciatic nerve neuropathy; Fatigue; vomiting; leg pain; pain in hip; Back pain; This spontaneous case was reported by a physician and describes the occurrence of SCIATIC NERVE NEUROPATHY (sciatic nerve neuropathy), FATIGUE (Fatigue), VOMITING (vomiting), PAIN IN EXTREMITY (leg pain), ARTHRALGIA (pain in hip) and BACK PAIN (Back pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SCIATIC NERVE NEUROPATHY (sciatic nerve neuropathy) (seriousness criterion medically significant), FATIGUE (Fatigue) (seriousness criterion medically significant), VOMITING (vomiting) (seriousness criterion medically significant), PAIN IN EXTREMITY (leg pain) (seriousness criterion medically significant), ARTHRALGIA (pain in hip) (seriousness criterion medically significant) and BACK PAIN (Back pain) (seriousness criterion medically significant). At the time of the report, SCIATIC NERVE NEUROPATHY (sciatic nerve neuropathy), PAIN IN EXTREMITY (leg pain), ARTHRALGIA (pain in hip) and BACK PAIN (Back pain) had not resolved and FATIGUE (Fatigue) and VOMITING (vomiting) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No corrective treatment was reported.
got shingles right after shingles vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 15-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media.  The reporter stated that the patient got shingles right after their shingles vaccine. This case has been linked with the case US2022AMR094585 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR094585:Same reporter
Woke up with swelling and redness in right arm around shot area, pain and fever and called the doctor and went in the office on 09/24/2013 around 1:00 PM and the Doctor prescribed diphenhydrAMINE Tablet which did no good so on Friday 09/27/2013 I ended up in the ER.
35 y.o. male report w/secondary bacteria infection to smallpox vax site. Quarter sized, circular, puritis? drainage to site on left arm. Mild odor noted with bandage removal. Meds: Dicloxacillin 250 mg PO.
2nd day starting have severe pain in the arm, called the pharmacy and the pharmacist told her she was suffering from a side effect from the shot her arm waS swollen he said to put an ice pack on it.  Now her right arm has filled up with pus and at the injection site she has a big knot.
Information has been received from a registered nurse concerning a 34 month old male child with a history of mild asthma and no allergies who on 29-JUN-2002 was vaccinated with the first dose of VARIVAX (Merck). There was no concomitant medication. In April 2004, the patient experienced a mild case of shingles. The mother of the child mentioned in the email she may hold off on her child getting the second dose of VARIVAX (Merck). There were no laboratory studies performed. The patient sought medical attention by the pediatrician but unknown if by phone or office visit. The patient had recovered. Additional information has been requested.
Patient noticed numbness starting in his left thigh and moved to his lower leg and feet.  It moved to his torso and it is not tingly and numb.  He did not see a doctor for this, but the numbness is still there.  He also feels "itchy" inside especially on his chest and armpit area.
Patient was admitted to Medical Specialty floor on 1/12/22 for observation due to having neurodegenerative dementia with behavioral disturbance. She is under a chapter 55 hold
Varicella vaccine administered to right arm 8/24 09.  Mom reports that his rt arm was painful that entire day.  They noticed swelling of the arm with increasing pain on 8/25/09 and today (8/26/09) noticed discoloration (red/maroon), increasing pain and continued swelling.  No other symptoms.  Patient is alert, active and having no respiratory symptoms.  She administered ice packs motrin & benadryl. She took him to be evaluated by his PCP, late afternoon 8/26.  No further report on patient condition available at this time.
About two weeks after receiving the 1st does of the Pfizer vaccine.. I started having slight ringing in my ears. It is most noticeable when going to bed or am in a very silent area.
pain of the jugulo-digastric (tonsilar), subparotid andpreauricular lymph nodes; Swelling and pain of the jugulo-digastric (tonsilar), subparotid, and preauricular lymph nodes; This is a spontaneous report received from a contactable consumer, the patient. A 28-years-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN via an unspecified route of administration in left arm on 19Mar2021 at 16:00 (at the age of 28-years-old) as a single dose, for COVID-19 immunisation. Medical history, concomitant medications of the patient were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN via an unspecified route of administration in left arm on 19Feb2021 at 12:00 (at the age of 28-years-old) as a single dose, for COVID-19 immunisation. The patient had not received any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient not had any allergies to medications, food, or other products. The patient experienced lymph node pain and swollen lymph nodes on 20Mar2021 at 15:45 (Swelling and pain of the jugulo-digastric (tonsillar), sub parotid, and preauricular lymph nodes that began one day after vaccination). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for events swollen lymph nodes and lymph node pain. The clinical outcome of lymph node pain and swollen lymph nodes was not resolved.   Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021324484 similar report from same reporter
About 16hrs after receiving vaccines child woke-up with left leg red and swelling. Child was unable to walk at the time She woke-up. Went to ER Dx: Vaccine reaction Dx: Left Leg pain
The Covid-19 Pediatric vaccine administered to the patient was inadvertently not diluted by the pharmacist. It was given at around 5:00 pm on March 4,2022. Upon discovering of the undiluted vaccine, the administering pharmacist called the patient's mother, apologized about the incident, explaining the vaccine was not diluted, and that the patient received a little stronger dose of the vaccine. The pharmacy manager also called Pfizer to inquire about what they could advise proper steps to do. As of this reporting, we are advised to report the incident to the VAERS website. The administering pharmacist advised the mother to monitor the patient and the pharmacist will also monitor the patient of unusual side effect. The patient's mother is not upset but the pharmacist deeply apologized about the unintentional vaccination of undiluted pediatric Covid-19 vaccine.
No additional Ae's reported; Temperature excursion involving administered PROQUAD vaccines; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Patient's medical history and concomitant medications were not provided.  On 21-DEC-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)(Reported Lot # U022726 and reported expiration date was : 16-JAN-2023) for prophylaxis after involving in temperature excursion (Product storage error). No additional Ae's and no PQC's were reported.
was tested positive for Covid; had fever; was tired; sore left arm; A spontaneous report was received from a consumer concerning a 62-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced sore left arm, had fever, was tired, was tested positive for Covid.   The patient's medical history was not provided. Concomitant medications reported were calcium.   On 13/Jan/2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 14/Jan/2021, the patient experienced sore left arm. On 22-JAN-2021 the patient experienced had fever and was tired. On 24/Jan/2021 the patient experienced was tested positive for Covid.  Treatment medications were not reported.   Action taken with mRNA-1273 in response to the events was not reported.     The events, sore left arm, was considered resolved on 24 Dec 2020. The outcome of the events had fever, was tired, was tested positive for Covid was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of pain in arm, pyrexia and fatigue, a causal relationship cannot be excluded.  Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.
Cellulitis at the site of injection. Patient was treated with antibiotics and is doing better now.
The patient developed myocarditis several days after receiving the vaccine. He was admitted to hospital and observed for several days before discharge in stable condition.
AROUND 5:05PM THE FLU VACCINE WAS ADMINISTERED. PATIENT RAPIDLY FELT DIZZY,PALE AND STARTED TO SWEAT. SHE THEN FAINTED AND THEN STARTED TO CONVULSE ,BUT THEN RAPIDLY CAME BACK TO HER SENSES. AFTER THAT SHE STILL FELT WEAK, DIZZY AND WAS VERY PALE. WE PROCEED TO CALL 911 AROUND 5;15PM. PATIENT NEVER STOPPED BREATHING. SHE SAYS THAT WHEN SHE FELT DIZZY SHE HAD LOST HER BALANCE AND HAD BLURRY VISION. AFTER THE PARAMEDICS ATTEND HER SHE WALKED OUT OF THE PHARMACY WITH THE PARAMEDICS. HER MOTHER WHO WAS WITH HER SAYS THAT THIS HAS HAPPEND BEFORE IN OTHER OCCASIONS TYPICALLY WHEN SHE GETS NERVOUS OR ANXIOUS BECAUSE SHE IS TERRIFIED OF NEEDLES. THIS HAS HAPPEND WHEN SHE IS GETTING A SHOT OR GETTING A BLOOD TEST DONE
This spontaneous report was received from a healthcare worker concerning an unspecified number of patients (demographics unknown). The patients' pertinent medical history and concurrent conditions were not provided. On unspecified dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (Lot # L004754; Expiration date: 10-NOV-2016) (dose and route were not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (light headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included LEVOTHYROXINE, FLUOXETINE, ATORVASTATIN and supplements for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (light headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Mar-2021, HEADACHE (light headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-089646 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089646:Dose 2
The patient was given Fluzone HD and he has an egg allergy.  He experienced swelling and rash at the injection site which resolved over 6 days by taking diphenhydramine.
Red rash on chest. Got the same rash when I got Covid back in January. I feel very light headed and  tired. Sore arm.  Took 2 Tylenol. Nothing has helped .
Soreness; Nausea; Fatigue; Headache; Joint pain; This case was reported by a physician via call center representative and described the occurrence of pain in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included vascular disorder. Concomitant products included prednisone.   On 20th February 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced pain, nausea, fatigue, headache and joint pain. On an unknown date, the outcome of the pain, nausea, fatigue, headache and joint pain were recovered/resolved.   It was unknown if the reporter considered the pain, nausea, fatigue, headache and joint pain to be related to Shingrix.  Additional case details were reported as follows: The case was reported by patient's husband. The reporter stated that the patient experienced soreness, nausea, fatigue, headache, join pain, for more than a week after vaccination. The reporter consented to follow up.
Patient received Moderna vaccine dose 2 at 0826. At 0842 patient c/o chest tightness, then he reported difficulty breathing, and then throat tightness. He further complained that he was having problems swallowing, felt like he was going to pass out. Eyes rolled. Did not lose consciousness. I called 9-1-1...at 0846, RN administered 0.3 mL epinephrine IM left thigh. BP at 0850 was 162/96, respirations = 18. HR at 0853 was 106, EMS arrived and transported patient to Local Hospital.
Narrative: COVID infection following COVID vaccine series 04/01, Pfizer, dose #1 04/22, Pfizer, dose #2 1/3 COVID swab, result: detected 12/23 pt cc: chills, cough, diarrhea, fever, headache, myalgias, rhinorrhea exposure: unknown 01/03 pt admit to ED cc: sore throat and a nonproductive cough dx: COVID-19 LOS: 1 day 01/33 CXR impression: No acute cardiopulmonary disease.
Fever 103°, chills, muscle aches, joint pain, headache, difficult breathing, weakness, ringing in ears
Chills and body aches - within two or three days after the vaccine and they resolved pretty quickly. I became symptomatic with general UTI symptoms on or about the 4th or 5th of April. I haven't had one of these for about 7 years. I went to  Urgent Care on 8th of April - I was put on two meds - antibiotic (Nitrofurantoin) and the other was for something to do with my bladder (Phenazopyridine). My symptoms have cleared up.
got a little bit sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (got a little bit sick) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (got a little bit sick). At the time of the report, MALAISE (got a little bit sick) outcome was unknown.            Concomitant medication details were not provided. Treatment details were not provided.   This case was linked to MOD21-152902 (Linked Report).; Sender's Comments:  MOD21-152902:
Information has been received from a nurse concerning an 18 year old female who on 20-JAN-2009 was vaccinated with her first dose of GARDASIL 0.5ml IM, lot number: 661703/0651X.  On approximately "2 or 3 days after vaccination" (22-JAN-2009 or 23-JAN-2009), the patient experienced red rash on her arm from shoulder to hand.  Subsequently, the patient recovered "2 weeks after the vaccination", on approximately 3-FEB-2009.  The patient sought medical attention, she saw the physician.  Additional information has been requested.
Developed blister, itchy, burning rash under rt. breast and a smaller area under left breast about 30 hours after second dose; Developed blister, itchy, burning rash under rt. breast and a smaller area under left breast about 30 hours after second dose; Looked like shingles; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received bnt162b2 (Pfizer COVID 19), via an unspecified route of administration, administered in right arm on 01Apr2021 14:30 (Lot Number: EP7533) as 2nd dose, single for COVID-19 immunization. Medical history included allergy to xray contrast dyes from an unknown date and unknown if ongoing. Concomitant medications included rosuvastatin; HCTZ; duloxetine; letrozole; esomeprazole magnesium (NEXIUM); all taken for an unspecified indication, start and stop date were not reported. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received 1st dose of bnt162b2 (Pfizer COVID 19), administered in right arm on 09Mar2021 10:45 AM (Lot Number: EN6199) for COVID-19 immunization. The patient developed blister, itchy, burning rash under rt. breast and a smaller area under left breast about 30 hours after second dose; looked like shingles on 02Apr2021 17:30 with outcome of recovered in Apr2021. Lasted about 4-5 days. The events were assessed as non-serious. No treatment was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Immediately got a bad taste upon injection. Within the minute following the injection my tongue and lips were tingling. I didn't say anything because I thought the taste caused the tingling. Approximately 30 minutes later my heart started to pound out of my chest for Approximately 3-5 minutes. I then felt light headed, had ringing in my ears and felt like I was going to pass out. I was taken to Urgent Care where they performed an ekg to make sure that it wasn't an effect from the injection and a possibke cardiac event. My ekg was normal. I went home, lips and tongue tingled until about 9pm, and started to lessen at that time. The next day, the tingling was gone. I felt off, so I took my BP with home machine through the day and it was lower than normal 102/62. It did fluctuate 1 or 2 #'s higher and lower throughout the day.  So I hydrated, and rested. By the next day I was fine
This spontaneous report as received from an 83 year old female consumer with penicillin allergy and sulfa allergy referring to herself. The patient's medical history included breast cancer. Historical therapies included ZOSTAVAX (Merck) on an unknown date in 2013 (also reported as last year). On 27-OCT-2014 the patient was vaccinated, at her physician's office, with PNEUMOVAX 23, 1 injection, in the right arm (dose, dose number, route, lot number and expiration date were not reported). Concomitant therapies included influenza virus vaccine (unspecified) (also reported as annual flu vaccine) on the left arm (also reported as the opposite arm) and a lot of miscellaneous prescription tablets and capsules. On 29-OCT-2014, patient experienced rash, redness and "puffiness" along with intense itching sensation on her right arm, where she was injected with the PNEUMOVAX 23. The patient stated that the area was hot to the touch. The patient went to the physician's office on 03-NOV-2014 (also reported as yesterday) and was told to out heat on the area. The patient also stated that her obstetrician and gynaecologist (OBGYN) told her to take BENADRYL and apply cold compresses. The outcome of the events was reported as not recovered. The relatedness between the events and PNEUMOVAX 23 was not reported. Additional information has been requested.
This is a spontaneous report received from contactable consumer or other non-HCP (patient). A male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for immunisation. The patient developed influenza-like illness (flu-like symptom), with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Patient received 1st dose of PFIZER COVID19 vaccine within 2 weeks of receiving the flu vaccine.
6 hours after receiving vaccine, patient experienced numb hands, severe shaking, sore throat, fever, vomiting, drop in oxygen level. Went to ER via ambulance. Was released with these Rx's: CIPRO, Prednisone, ZOFRAN.